Ismita Chhetri retweeted
🚨New Paper Open Access🚨Safety and Feasibility
Assessment of Repetitive Vascular Occlusion Stimulus (RVOS) Application to Multi-Organ Failure Critically Ill Patients: A Pilot Randomised Controlled Trial mdpi.com/2077-0383/11/14/393… @hugh_montgomery – at Florida, USA
All smiles at @UniOfSurrey graduation today! Thank you @hunt4jules and @drbencb for being the best PhD supervisors. Your support and guidance will stay with me lifelong! #SurreyGrad
Ismita Chhetri retweeted
📢 Join our online workshop on 'Grant Writing' organized jointly by IIHMR Delhi and Imperial College London - Funded by NIHR RIGHT Grant via the PREVENT study.
Dates: 19 - 22 April 2022
To register your interest, kindly visit: forms.office.com/r/Z1mzTd9YJ…
preventstudy.org/capacity-bu…
Ismita Chhetri retweeted
📢 Applications invited for the post of Computer Scientist with experience in Magnetic Resonance Imaging/Magnetic Resonance Physicist @CPN_NeoNeuro. The post is primarily based in India, with short periods in the UK. For more details, visit: tinyurl.com/yckshhxb
Ismita Chhetri retweeted
Understanding the anti-inflammatory mechanism of #inorganicnitrate derived #nitricoxide with @ProfAhluwalia Not possible without support from @TheBHF and @Barts_Charity Now, to improve outcomes in #heartfailure @BeetrootHearts? @ESC_Journals #ESCCongress https://teapawt.net/t.co/YWJrs8Ar13
Ismita Chhetri retweeted
Hugely proud of our #ESCAbstract on the #ESCCongress Research Gateway cyim.page.link/5xTM via @escardio @ProfAhluwalia @QMULWHRI @krishnaraj82 @DrVikasKapil @IsmitaChhetri
Ismita Chhetri retweeted
🚨UPDATE to DiNOVasc-COVID-19 study🚨DiNOVasc-COVID-19 is now open to HEALTHY VOLUNTEERS awaiting ANY of their 1ST, 2ND or BOOSTER COVID vaccines! Short clinical study (2x <2h in-person visits). Aged 18-60? Time/travel compensated. Contact [email protected], get involved!
Ismita Chhetri retweeted
HEALTHY VOLUNTEERS NEEDED for a SHORT study at WHRI! NOT had your COVID vaccine yet? Aged 18-60? We are looking at the effects of gender and nitrate on blood vessels after the COVID vaccine. Time & travel compensated. Contact Asad Shabbir on 07716096364 or [email protected]
Ismita Chhetri retweeted
T-cell immune responses in #AcuteCoronarySyndrome are driven by #interleukin 7 & 15. Is there a role for IL-7/IL-15 signaling inhibition with #Tofacitinib in #MI? https://teapawt.net/t.co/aqcZP9tQo2
@CVR_TomaszGuzik @AIAntonopoulos
#inflammation #atherosclerosis #CardiovascularResearch
Ismita Chhetri retweeted
One of #OurNHSHeroes Edgar went home yesterday after recently being discharged from ICU. His friends and colleagues gave him a very warm goodbye! Well done, Edgar.














